期刊文献+

多囊卵巢综合征患者血清瘦素水平的变化及临床意义 被引量:2

Changes and clinical significance of serum leptin levels in patients with polycystic ovarian syndrome
下载PDF
导出
摘要 目的研究多囊卵巢综合征(PCOS)患者血清瘦素水平变化及其临床意义。方法初次诊断为PCOS的170例患者根据体质量指数(BMI)分为正常体质量组(P1组,n=69)、超重组(P2组,n=44)和肥胖组(P3组,n=57)。酶联免疫吸附法检测血清瘦素水平,分析BMI、腰臀比及血糖、胰岛素和血脂水平以及胰岛素抵抗指数(HOMA-IR)和胰岛B细胞分泌功能指数(HOMA-IS)与血清瘦素水平的相关性。以年龄和体质量指数(BMI)相匹配的143名健康志愿者作为正常对照,且同样分为正常体质量组(C1组,n=102)、超重组(C2组,n=20)和肥胖组(C3组,n=21)。结果血清瘦素水平检测和分析结果显示,P1组与C1组比较差异无统计学意义;但P2组>C2组,P3组>C3组,差异均有统计学意义(P<0.01)。Spearman相关分析显示,PCOS患者血清瘦素水平与BMI、腰臀比以及血清三酰甘油、高密度脂蛋白胆固醇、空腹及餐后2 h血胰岛素、空腹及餐后2 h血糖、HOMA-IR、HOMA-IS相关;进一步的多元逐步回归分析结果表明,PCOS患者血清瘦素水平与BMI和HOMA-IR独立相关。结论PCOS的发生和发展可能与血清瘦素水平升高导致糖脂代谢异常有关。 Objective To investigate the changes and clinical significance of serum leptin levels in patients with polycystic ovary syndrome (PCOS). Methods One hundred and seventy women initially diagnosed with PCOS were divided into normal body weight group ( P1 group, n = 69), overweight group ( P2 group, n = 44) and obesity group (P3 group, n = 57) according to body mass index (BMI). Serum leptin levels were detected by enzyme linked immunosorbent assay, and the relationship between serum leptin level and BMI, waist to hip ratio, blood glucose, blood insulin, blood lipid, insulin resistance index (HOMA-IR) and pancreatic island B cell secretion function index (HOMA-IS) was explored. One hundred and forty-three age- and BMl-matched healthy volunteers were served as normal controls, and were also divided into normal body weight group ( C1 group, n = 102), overweight group (C2 group, n = :20) and obesity group (C3 group, n = 21). Results The detection and analysis of serum leptin levels indicated that there was no significant difference between P1 group and C1 group, while P2 group was significantly higher than C2 group (P 〈 0.01), and P3 group was significantly higher than C3 group (P 〈0.01). Spearman correlation analysis revealed that serum leptin level was related to BMI, waist to hip ratio, serum triglyceride, high density lipoprotein-cholesterol, fasting and 2 h post-prandial blood glucose, fasting and 2 h post-prandial blood insulin, HOMA-IR and HOMA-IS. Multiple regression analysis demonstrated that serum leptin was independently related to BMI and HOMA-IR. Conclusion The increase of serum leptin may lead to abnormal glucolipid metabolism, which may contribute to the development of PCOS.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2010年第3期325-328,共4页 Journal of Shanghai Jiao tong University:Medical Science
基金 上海市科委资助项目(08411953000)~~
关键词 多囊卵巢综合征 瘦素 体质量指数 胰岛素抵抗 polycystic ovary syndrome leptin body mass index insulin resistance
  • 相关文献

参考文献9

  • 1Baranowska B, Radzikowska M, Wasilewska-Dziubifska E, et al. Neruopeptide Y, leptin, galanin and insulin in women with polycystle ovary syndrome [ J ]. Gynecol Endocrinol, 1999, 13 (5) : 344 - 351.
  • 2Seron K, Corset L, Vasseur F, et al. Distinct impaired regulation of SOCS3 and long and short isoforms of the leptin receptor in visceral and subcutaneous fat of lean and obese women [ J ]. Biochem Biophys Res Commun, 2006, 348(4): 1232- 1238.
  • 3Pehlivanov B, Mitkov M. Serum leptin levels correlate with elinieal and biochemical indices of insulin resistance in women with polycystie ovary syndrome[J]. Eur J Contracept Reprod Health Care, 2009, 14(2) : 153 - 159.
  • 4郭跃贞,夏丽,韩爱民,程丽萍,周岩,周永安,武坚锐.多囊卵巢综合征患者血清中瘦素水平与胰岛素抵抗关系的研究[J].中国优生与遗传杂志,2008,16(9):35-36. 被引量:5
  • 5Muller G, Ertl J, Gerl M, et al. Leptin impairs metabolic actions of insulin in isolated rat adipocytes [ J ]. J Biol Chem, 1997, 272 (16) : 10585 - 10593.
  • 6郭涛,黄薇,李国华,王宇翮,何礼霞,尚晓飞.瘦素、脂联素及抵抗素在多囊卵巢综合征治疗中的变化[J].实用妇产科杂志,2007,23(11):669-672. 被引量:5
  • 7Vicennatib V, Gambinerib A, Calzonib F, et al. Serum leptin in obese women with polycystic ovary syndrome is correlated with body weight and fat distribution but not with androgen and insulin levels [J]. Metabolism, 1998, 47(8): 988-992.
  • 8Vardhana PA, Dicken C, Tortoriello DV, et al. Increasing adiposity in normal ovulatory women affects adipocytokine expression in subcutaneous and visceral abdominal fat [ J]. Int J Gynaecol Obstet, 2009, 104(2): 121- 124.
  • 9Carmina E, Chu MC, Moran C, et al. Subcutaneous and omental fat expression of adiponectin and leptin in women with pulyeystic ovary syndrome[J]. Fertil Steril, 2008, 89(3) : 642 -648.

二级参考文献17

  • 1Sepilian V, Nagamani M. Effects of Rosiglitazone in Obese Women with Polyeystic Ovary Syndrome and Severe Insulin Resistance [J]. J Clin Endocrin Metab, 2005, 90( 1 ) : 60 - 65.
  • 2Erturk E, Kum N, Savci V, et al. Serum leptin levels correlate with obesity parameters but not with hyperinsulinism in women with polycystic ovary syndrome [J]. Fertil Steril, 2004, 82(5) : 1364- 1368.
  • 3Ardaw MSM, Rouzi AA. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome [J]. Fertil Steril, 2005, 83(6): 1708- 1716.
  • 4Lee JH, Chan JL, Yiannakonris N, et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration-cross-sectional and interventional studies in normal, insulin-resistant and diabetic subjects [J]. J Clin Endocinol Metab, 2003, 88(10): 4848 -4856.
  • 5Mendonca HC, Montenegro Junior RM, Foss MC, et al. Positive correlation of serum leptin with estradiol levels in patients with palycystic ovary syndrome [J]. Braz J Med Biol Res, 2004, 37(5): 729-736.
  • 6Geisthovd F. A comment on the European Society of Human Reproduction and Embryology/American Society for Reproductive Medicine consensus of the polycystic ovarian syndrome, [ J ] . Reprod Biomed Online, 2003, 7 (6): 602-605.
  • 7Legro RS, Strauss JF, Molecular progress in infertility: polycystic ovary syndrome [J]. Fertil Steril, 2002, 78 (3) : 569 - 576.
  • 8Carmina E, Orio F, Palomba S, et al. Evidence for altered adipocyte function in polycystic ovary syndrome [J]. Eur J Endocrin, 2005, 152(3): 389 - 394.
  • 9Leroy P, Dessolin S, Villageois P, et al. Expression of ob gene in adipose cells Regulation by insulin [J]. J Biol Chem, 1996, 271(5): 2365- 2368.
  • 10Sandhofer A, Laimer M, Ebenbichler CF, et al. Soluble Leptin Receptor and Soluble Receptor-Bound Fraction of Leptin in the Metabolic Syndrome [J]. Obesity Research, 2003, 11(6):760-768.

共引文献8

同被引文献42

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部